Viktor R. Drel
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Physiology top 2%
- Pain Mechanisms and Treatments
- Biochemical effects in animals
- Adipose Tissue and Metabolism
Papers in
- Physiology 29
- Pain Mechanisms and Treatments 17
- Biochemical effects in animals 9
- Nitric Oxide and Endothelin Effects 4
- Co-authors
- Irina G. Obrosova (31 shared papers)Olga Ilnytska (10 shared papers)Pál Pacher (9 shared papers)Valeriy V. Lyzogubov (8 shared papers)Nazar Mashtalir (6 shared papers)Martin J. Stevens (3 shared papers)Mark A. Yorek (4 shared papers)Jerry L. Nadler (7 shared papers)
- Journals
- Diabetes (7 papers)The FASEB Journal (4 papers)Free Radical Biology and Medicine (4 papers)International Journal of Molecular Medicine (2 papers)Endocrinology (2 papers)
- Partner nations
- United StatesUkraineUnited Kingdom
In The Last Decade
Viktor R. Drel
48 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 105
- Clinical Biochemistry 310
- Physiology 1.1k
- Neurology 360
- Geriatrics and Gerontology 81
- Endocrinology, Diabetes and Metabolism 374
Countries citing papers authored by Viktor R. Drel
This map shows the geographic impact of Viktor R. Drel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor R. Drel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor R. Drel more than expected).
Fields of papers citing papers by Viktor R. Drel
This network shows the impact of papers produced by Viktor R. Drel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor R. Drel. The network helps show where Viktor R. Drel may publish in the future.
Co-authors
The 25 scholars most cited alongside Viktor R. Drel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 228 | |
| 2 | 2006 | 220 | |
| 3 | 2005 | 201 | |
| 4 | 2007 | 189 | |
| 5 | 2006 | 128 | |
| 6 | 2007 | 113 | |
| 7 | 2007 | 100 | |
| 8 | 2011 | 91 | |
| 9 | 2007 | 90 | |
| 10 | 2006 | 88 | |
| 11 | 2006 | 85 | |
| 12 | 2006 | 77 | |
| 13 | 2005 | 76 | |
| 14 | 2010 | 74 | |
| 15 | Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. | 2008 | 74 |
| 16 | 2011 | 72 | |
| 17 | 2007 | 63 | |
| 18 | 2020 | 62 | |
| 19 | 2009 | 60 | |
| 20 | 2016 | 57 |
About Viktor R. Drel
Viktor R. Drel is a scholar working on Physiology, Molecular Biology, Neurology, Oncology and Clinical Biochemistry, having authored 51 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (17 papers), Biochemical effects in animals (9 papers), PARP inhibition in cancer therapy (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers), Botulinum Toxin and Related Neurological Disorders (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Advanced Glycation End Products research (4 papers) and Neurological Disorders and Treatments (4 papers). The work is most often cited by research in Clinical Biochemistry (310 citations), Physiology (1.1k citations), Neurology (360 citations), Geriatrics and Gerontology (81 citations) and Endocrinology, Diabetes and Metabolism (374 citations). Viktor R. Drel has collaborated with scholars based in United States, Ukraine and United Kingdom. Frequent co-authors include Irina G. Obrosova, Olga Ilnytska, Pál Pacher, Valeriy V. Lyzogubov, Nazar Mashtalir, Martin J. Stevens, Mark A. Yorek, Jerry L. Nadler, Jeho Shin and Hanna Shevalye. Their work appears in journals such as Diabetes, The FASEB Journal, Free Radical Biology and Medicine, International Journal of Molecular Medicine and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.